Article: CIBA Vision Corporation and QLT PhotoTherapeutics Inc. announce Visudyne therapy filed with the European Medicines Evaluation Agency.

Article: NOVARTIS: Ciba Vision and QLT Phototherapeutics an ...
M2 Presswire;  October 7, 1999 ;     700+ words ... ... NOVARTIS: Ciba Vision and QLT Phototherapeutics ... review for Visudyne Therapy (C)1994 ... approval, CIBA Vision and QLT expect Visudyne therapy will be available ... Companies CIBA Vision and QLT are ... developing Visudyne therapy for the ...

Article: CIBA Vision and QLT PhotoTherapeutics Announce FDA ...
PR Newswire;  October 4, 1999 ;     700+ words ... ... approval, CIBA Vision and QLT expect Visudyne therapy will be available ... Companies CIBA Vision and QLT are ... developing Visudyne therapy for the treatment ... commercialization, CIBA Vision will market ... manufacturing. Visudyne therapy is ...

Article: QLT and CIBA Vision announce regulatory submission ...
PR Newswire;  August 16, 1999 ;     700+ words ... ... President of CIBA Vision's worldwide ... The approval of Visudyne therapy has the potential ... vision loss. Visudyne therapy does not appear ... Background on CIBA Vision and QLT: Visudyne therapy is being co ...

Article: NOVARTIS: Novartis' eye-care unit CIBA Vision and ...
M2 Presswire;  January 6, 1999 ;     700+ words ... ... developed by QLT and CIBA Vision. Results of the TAP ... patients treated with Visudyne therapy were more likely to ... month results, QLT and CIBA Vision anticipate filing for regulatory approval of Visudyne therapy in the U.S., Canada ...

Article: CIBA Vision and QLT Announce ...
PR Newswire;  September 13, 1999 ;     700+ words ... ... PRNewswire/ -- CIBA Vision, the eye care ... clinical program for Visudyne therapy for the treatment ... allows us to offer Visudyne therapy immediately to ... President of CIBA Vision's Worldwide ... until approval, CIBA Vision and QLT ...

Article: CIBA Vision, the eye care unit of Novartis, and QLT ...
PR Newswire;  November 17, 1999 ;     700+ words ... ... concluded that Visudyne therapy was most appropriate ... co-developers CIBA Vision, the eye care ... implications for QLT and CIBA Vision, but it has the ... About AMD and Visudyne therapy Wet AMD typically ... commercialization, CIBA Vision will market ...

Article: HEALTH CARE FINANCING ADMINISTRATION ISSUES NATIONAL COVERAGE ...
PR Newswire;  November 10, 2000 ;     700+ words ... ... Zeiss Group, based in Germany. Visudyne therapy is being co-developed for various ocular conditions by CIBA Vision and QLT Inc. CIBA Vision markets ... responsible for manufacturing. Visudyne therapy is protected by a series of US ...